Nanjing Vazyme Biotech Co., Ltd.
SSE:688105.SS
22.71 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||||||||
| Net Income
| 0 | 0 | 1.997 | 10.943 | 5.216 | 5.433 | 4.704 | -30.47 | -51.209 | -155.991 | 135.794 | 182.582 | 431.359 | 128.072 | 158.359 | 55.344 | 336.514 | 216.642 | 152.102 | 339.051 | 113.93 |
| Depreciation & Amortization
| 0 | 0 | 0 | 53.289 | 53.289 | 55.793 | -76.261 | 62.024 | 62.024 | 74.206 | 74.206 | 34.259 | 34.259 | 25.304 | 25.304 | 21.13 | 0 | 13.727 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 10.414 | 0 | 0 | 0 | 533.924 | -603.54 | 0 | -35.047 | -4.919 | 819.096 | 0 | -15.006 | 4.496 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 38.03 | 0 | 19.074 | -3.735 | 3.735 | 0 | 7.375 | -3.735 | 3.735 | 0 | 7.469 | -3.735 | 3.735 | 0 | 10.617 | 0 | 0 | 0 |
| Change In Working Capital
| 0 | 0 | 0 | -144.794 | 0 | 435.577 | -466.466 | 466.466 | 0 | -1,086.712 | 789.181 | -789.181 | 0 | -274.676 | 160.57 | -160.57 | 0 | -281.951 | 0 | 0 | 0 |
| Accounts Receivables
| 0 | 0 | 0 | -150.676 | 0 | 534.672 | -597.237 | 597.237 | 0 | -682.891 | 287.437 | -287.437 | 0 | -133.201 | 28.09 | -28.09 | 0 | -164.364 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | -26.811 | 0 | -124.372 | 130.772 | -130.772 | 0 | -403.821 | 501.744 | -501.744 | 0 | -148.944 | 136.214 | -136.214 | 0 | -128.205 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.735 | 0 | -7.375 | 3.725 | -3.725 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0 | 0 | 0 | 32.692 | 0 | 25.276 | -3.735 | 3.735 | 0 | 7.375 | -3.725 | 3.725 | 0 | 7.469 | -3.735 | 3.735 | 0 | 10.617 | 0 | 0 | 0 |
| Other Non Cash Items
| -39.914 | 0 | -29.175 | 61.875 | -79.146 | 236.99 | -55.534 | 255.631 | -62.024 | 1,040.178 | -854.733 | -67.909 | -431.359 | 555.185 | -158.359 | -55.344 | -336.514 | -216.642 | -152.102 | -339.051 | -113.93 |
| Operating Cash Flow
| -39.914 | 0 | -16.764 | 19.53 | -73.93 | 186.63 | -63.367 | 153.845 | -51.209 | -155.991 | 135.794 | 182.582 | -0 | 317.527 | -8.923 | 71.364 | 240.017 | 283.476 | 101.562 | 0 | 0 |
| Investing Activities: | |||||||||||||||||||||
| Investments In Property Plant And Equipment
| -13.45 | -2.281 | -30.346 | -12.607 | -29.661 | 7.713 | -66.893 | -79.253 | -94.468 | -196.261 | -152.621 | -238.011 | -375.968 | -45.598 | -71.619 | -82.404 | -62.339 | -51.81 | -32.755 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0.307 | 0.171 | 1.13 | -9.536 | 17.833 | -8.314 | 460.46 | 45.946 | 0 | -0 | 0 | 2.726 | 72.201 | 0 | 0.5 | 51.832 | 32.907 | 0 | 0 |
| Purchases Of Investments
| -1,782.589 | -2,266.752 | -1,530.022 | -1,945.126 | -956.832 | -1,921.141 | -1,844.57 | -482.071 | -1,758 | -2,519.244 | -1,985.664 | -2,799.306 | -1,859 | -2,542.759 | -724.524 | 0 | -1,934 | -1,299.616 | -1,611.141 | 0 | 0 |
| Sales Maturities Of Investments
| 1,421.581 | 2,449.162 | 1,206.84 | 2,015.656 | 1,454.856 | 1,903.192 | 966.502 | 1,142.269 | 1,297.54 | 2,439.987 | 2,242.492 | 3,063.046 | 1,530.452 | 1,608.729 | 604.862 | 0 | 1,739 | 1,204.511 | 1,162.554 | 0 | 0 |
| Other Investing Activites
| -15.103 | 0.866 | -8.979 | 82.981 | 506.721 | 1.062 | -13.5 | 13.5 | -460.46 | 7.084 | -163.009 | 7.64 | 0 | 1.108 | -71.619 | -5.214 | -253.654 | -51.81 | -32.755 | -247.507 | -57.44 |
| Investing Cash Flow
| -389.562 | 180.996 | -362.201 | 58.093 | 469.493 | -19.772 | -940.629 | 586.131 | -554.928 | -222.488 | -58.801 | 33.369 | -704.516 | -978.521 | -190.698 | -5.214 | -253.654 | -146.894 | -481.19 | -247.507 | -57.44 |
| Financing Activities: | |||||||||||||||||||||
| Debt Repayment
| 342.102 | 92.446 | -26.828 | -414.493 | -269.946 | -124.407 | 73.8 | 146.821 | 726 | 15.59 | 207.915 | 0 | 0 | 0 | -8.461 | 0 | -8.902 | 0 | -41.91 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,113.773 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | -100.023 | 0 | -20.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | -28.078 | -34.554 | -9.827 | -7.904 | -9.796 | -8.937 | -511.618 | -2.975 | -120.003 | -120.003 | -120.003 | 0 | -1.777 | -0.866 | -0.775 | -1.027 | -0.021 | -0.387 | 0 | 0 |
| Other Financing Activities
| -43.324 | 16.938 | -3.525 | 56.412 | -56.889 | 9.241 | -0.129 | -14.689 | 0 | -4.302 | -121.286 | -8.329 | 72.73 | 2,100.846 | -0 | -10.04 | 0 | -2.715 | -0.1 | -21.556 | 327.89 |
| Financing Cash Flow
| 298.778 | 81.306 | -64.908 | -467.93 | -334.739 | -144.973 | 64.734 | -379.486 | 723.025 | 0.752 | 206.632 | -252.546 | 72.73 | 2,099.069 | -9.327 | -10.04 | -9.929 | -2.735 | -42.397 | -21.556 | 327.89 |
| Other Information: | |||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | -4.39 | 1.433 | -1.12 | -0.16 | -1.057 | -0.552 | 2.819 | 0.253 | 5.543 | -0.492 | 1.685 | -1.694 | -1.659 | 0.185 | -1.162 | 0.318 | -3.043 | -1.928 | 0 | 0 |
| Net Change In Cash
| 0 | 348.221 | -442.439 | -822.749 | -602.218 | 72.126 | -939.813 | 363.308 | 59.277 | 391.11 | 144.102 | -34.91 | -633.48 | 1,436.416 | -208.764 | -210.423 | -485.185 | 130.803 | -423.953 | -269.063 | 270.45 |
| Cash At End Of Period
| 295.912 | 423.21 | 74.989 | 541.922 | 1,364.672 | 1,966.89 | 827.363 | 1,767.176 | 1,403.868 | 1,344.591 | 953.481 | 809.379 | 844.289 | 1,477.77 | 41.354 | -15.254 | -263.584 | 221.602 | 90.799 | -269.063 | 270.45 |